FAM
ARNA

Fred Alger Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Fred Alger Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,000
Closed -$762K – 557
2019
Q2 		$762K Buy
+13,000
New +$672K ﹤0.01% 359

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fred Alger Management's ARNA Position: Q3 2019 in Review

Fred Alger Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 13,000 shares — an estimated $762K sold.

Fred Alger Management first reported a position in ARNA in Q2 2019 and held it in 1 quarter. The position peaked at $762K in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Fred Alger Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Fred Alger Management sold 13,000 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $762K.
  • Fred Alger Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 1 quarter.
  • Fred Alger Management's Arena Pharmaceuticals Inc position peaked at $762K in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Fred Alger Management's 13F filing for Q3 2019, filed 14 Nov 2019.